U.S. markets open in 5 hours

Eloxx Pharmaceuticals, Inc. (ELOX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.3700+0.0200 (+1.48%)
At close: 4:00PM EDT

1.4500 +0.08 (5.84%)
Pre-Market: 4:29AM EDT

Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
6/30/2017
Total Revenue
0
0
0
0
0
0
Operating Expense
28,078
29,437
50,555
46,971
20,390
2,143
Operating Income
-28,078
-29,437
-50,555
-46,971
-20,390
-2,143
Net Non Operating Interest Income Expense
-1,165
-1,072
-544
594
-668
-1,683
Other Income Expense
-82
-4,068
225
-686
-156
-3,011
Pretax Income
-29,325
-34,577
-50,874
-47,063
-21,214
-6,836
Tax Provision
-
0
0
122
-
-1,040
Net Income Common Stockholders
-29,325
-34,577
-50,874
-47,185
-23,618
-6,194
Diluted NI Available to Com Stockholders
-29,325
-34,577
-50,874
-47,185
-23,618
-6,194
Basic EPS
-
-
-1.34
-1.45
-4.75
-5.40
Diluted EPS
-
-
-1.34
-1.45
-4.75
-5.40
Basic Average Shares
-
-
38,063
32,437
4,976
1,161
Diluted Average Shares
-
-
38,063
32,437
4,976
1,161
Total Operating Income as Reported
-28,102
-33,455
-50,555
-47,565
-20,390
-4,593
Total Expenses
28,078
29,437
50,555
46,971
20,390
2,143
Net Income from Continuing & Discontinued Operation
-29,325
-34,577
-50,874
-47,185
-21,214
-5,796
Normalized Income
-29,243
-30,509
-51,099
-46,684
-21,058
-3,243
Interest Income
92
337
1,072
601
-
-
Interest Expense
1,257
1,409
1,616
7
43
265.203
Net Interest Income
-1,165
-1,072
-544
594
-668
-1,683
EBIT
-28,068
-33,168
-49,258
-47,056
-21,171
-6,571
EBITDA
-27,470
-
-
-
-
-
Reconciled Depreciation
598
571
559
216
39
44.075
Net Income from Continuing Operation Net Minority Interest
-29,325
-34,577
-50,874
-47,185
-21,214
-5,796
Total Unusual Items Excluding Goodwill
-82
-4,068
225
-686
-156
-3,011
Total Unusual Items
-82
-4,068
225
-686
-156
-3,011
Normalized EBITDA
-27,388
-28,529
-48,924
-46,154
-20,976
-3,516
Tax Rate for Calcs
0
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
-185.22
0
-457.6174